I am a passionate and dedicated physician with nearly 2 decades of experience in Medical Affairs and Oncology within the pharmaceutical industry, encompassing national, regional, and global roles. Currently, I serve as the Senior Vice President and Head of Medical Affairs EMEA at Merck, where I have transformed the regional Medical Affairs structure and capabilities in the largest territory for Merck. My strategic vision has elevated Medical Affairs to that of a respected partner function to both Development and Commercial sectors. Key Highlights: Leadership & Transformation: Spearheaded the integration of affiliate Medical Affairs into R&D, fostering a robust, two-way communication channel from Global to Local levels. This initiative has significantly enhanced the strategic alignment and scientific credibility of our Medical Affairs function. Team Development: Managed a dynamic team of 450 professionals, achieving a double-digit increase in employee engagement year-on-year. This has created an environment where Medical Affairs professionals are deeply committed and aligned with the company’s mission. Strategic Partnerships & Alliances: Played a pivotal role in signing key alliances with Pfizer and GSK, and the strategic divestment of several business units, contributing to the broader organisational strategy and commercial success. Oncology Leadership: Previously led the Global Oncology Medical Affairs team, revitalising our customer and patient-driven approach, and leveraging Global-Regional-Local relationships to enhance the success of our Oncology portfolio, including the development of Erbitux and our Immuno-Oncology pipeline. With keen commercial awareness, award-winning communication skills, and exceptional KOL engagement abilities, I have facilitated unprecedented EMEA approvals and national endorsements. My comprehensive medical and scientific training, coupled with my strategic and collaborative leadership style, enables me to drive positive change and deliver impactful results in a highly dynamic and regulated pharmaceutical industry. I am committed to continuous improvement and innovation, ensuring that our medical strategies not only meet regulatory requirements but also significantly enhance patient outcomes and drive business growth.